Received Mar 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | X014788 | OT |
No symptomatic events.; administration of expired GARDASIL-9.; a T/E that had previously occurred; This spontaneous report was received from an other health professional and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 24-Aug-2024, the vaccine Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) had temperature excursion of 51F for 1 hours 12 minutes 0 seconds. There was no previous excursion. On 21-Mar-2025, the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) Injection (0.5 ml, lot #X014788 has been verified to be a valid lot number, expiration date: 07-Mar-2025; strength was not provided) by intramuscular route for prophylaxis (expired product administered, product storage error). No symptomatic events were reported (no adverse event).